Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser

EU orphan designation number: EU/3/16/1721   
Active ingredient: L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
Indication: Prevention of graft loss in pancreatic islet transplantation
Sponsor: Araim Pharmaceuticals Europe Limited
Riverside One, Sir John Rogerson's Quay, Dublin 2, D02 X576, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/094/16 (2016)5628 of 29/08/2016
3/04/2019 Transfer of orphan designation EMA/OD/0000005497 (2019)2676 of 1/04/2019